V-Bio Ventures
Overview
V-Bio Ventures is a life science venture capital firm that specializes in building and financing young, innovative companies in the therapeutics, diagnostics, and agricultural sectors across Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AgomAb Therapeutics | Mar 2021 | Series B | Co-investor |
| AstriVax | Aug 2022 | Seed | Lead |
| Orionis Biosciences | Oct 2015 | Series A | Co-investor |
| Avidicure | Apr 2025 | Seed | Co-investor |
| Corteria Pharmaceuticals | Sep 2023 | Series A | - |
For institutional investors. Book with your work email.
Key People
Shelley Margetson
Managing Partner
Willem Broekaert
Managing Partner
Mathias Falcenberg
Venture Partner
🧪 Ward Capoen
Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is V-Bio Ventures based?
V-Bio Ventures is headquartered in Belgium.
When was V-Bio Ventures founded?
V-Bio Ventures was founded in 2015.
How many portfolio companies does V-Bio Ventures have?
V-Bio Ventures has 22 portfolio companies in Caplight's dataset.
What are some companies in V-Bio Ventures's portfolio?
Portfolio companies visible on Caplight include AgomAb Therapeutics, AstriVax, Orionis Biosciences, Avidicure, Corteria Pharmaceuticals.
What was V-Bio Ventures's most recent investment shown here?
V-Bio Ventures's most recent investment in this portfolio sample was in Avidicure in 2025.
What sectors does V-Bio Ventures focus on?
V-Bio Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences.
What company stages does V-Bio Ventures focus on?
V-Bio Ventures typically invests at the Early stage.
What is V-Bio Ventures's AUM?
V-Bio Ventures's assets under management are estimated between $202.7M and $202.7M.